Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | CPT2 | P23786 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ACACA | Q13085 | 1/20 | 0.38 |
| ▸ | ARG1 | P05089 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27419488 | 0.83 | GGPS1 (0.47) | FFAR1TDP1TSHRALDH1A1 | |
| SCHEMBL31279948 | 0.82 | FFAR1 (0.43) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL31280480 | 0.82 | FFAR1 (0.43) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL7161723 | 0.80 | ACLY (0.61) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL4035472 | 0.80 | ACLY (0.61) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL27754242 | 0.80 | ACLY (0.61) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL31280652 | 0.79 | FFAR1 (0.39) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL31096475 | 0.78 | ALDH1A1 (0.42) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL5795040 | 0.77 | ACLY (0.57) | FFAR1CPT2TDP1ACLYACACB | |
| SCHEMBL18937039 | 0.77 | CA2 (0.41) | FFAR1TDP1TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3190131-B1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | UNIV KYOTO (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-10414848-B2 | Living radical polymerization initiator, method for producing polymer, and polymer | KYOTO UNIVERSITY (JP) | 2019-09-17 | — | — | US | disclosed |
| US-20170306073-A1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | KYOTO UNIVERSITY (JP) | 2017-10-26 | — | — | US | disclosed |
| EP-3190131-A1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | Kyoto University (JP) | 2017-07-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10414848-B2 | Living radical polymerization initiator, method for producing polymer, and polymer | CCNY, MTR, PARN | FFAR1 1324/4885CPT2 1638/4885TDP1 2326/4885 |
| US-20170306073-A1 | LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER | CCNY, MTR, PARN | FFAR1 1324/4885CPT2 1638/4885TDP1 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.